Erin Butler - 30 Dec 2025 Form 4 Insider Report for ImageneBio, Inc. (IKNA)

Reporting relationship: Principal Accounting Officer
Issuer ticker: IKNA
Reported as of: 30 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jan 2026, 21:15:55 UTC
Prior SEC filing: 29 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Erin Butler

Key filing fact

Erin Butler filed Form 4 for ImageneBio, Inc. (IKNA) on 02 Jan 2026.

Key facts

This page summarizes Erin Butler's Form 4 filing for ImageneBio, Inc. (IKNA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Jan 2026, 21:15.

Change

Previous filing in this sequence was filed on 29 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001940413 Primary reporting owner

Butler Erin

Relationship: Principal Accounting Officer
Address: C/O IMAGENEBIO, INC., 12526 HIGH BLUFF DRIVE, SUITE 345, SAN DIEGO
Signature: /s/ Erin Butler
Signature date: 02 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMA transaction

Common Stock

Award

Transaction value: $0
Shares: +22,500
Change %: +737%
Price: $0.000000
Shares after: 25,551
Date: 30 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMA transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +22,500
Change %
Price: $0.000000
Shares after: 22,500
Date: 30 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,500
Exercise price: $7.11
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares of the Issuer's common stock ("Common Stock") underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of RSUs will vest and settle into Common Stock on July 15, 2026, March 1, 2027, March 1, 2028 and March 1, 2029, in each case, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan (the "2025 Plan")) through each such date.

Footnote F2

This option vests over four years, with 25% of the shares subject to this option vesting on July 15, 2026, and the remaining shares vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2025 Plan) through each such date.